High impactTop Intelligence

FDA Faces 1,300+ Staffing Gap as Pharma Regulatory Delays Mount

NewsData.io · United States · Nov 11, 2026

The FDA's drug and biologics divisions are operating with 1,343 fewer employees than a year ago across CBER and CDER, following mass departures, layoffs, and early retirement offers in 2025. The agency had a hiring target of roughly 2,200 open positions as of June, but qualified candidates are being deterred by past abrupt firings and HR bottlenecks slowing onboarding. Drug developers report more inconsistent FDA reviews, communication breakdowns, and slower informal feedback channels. Staffing firms with life sciences and regulatory affairs specialties may see increased demand as pharma companies seek external expertise to navigate the FDA's reduced capacity.

Get the weekly brief by email

What changed in staffing last week, every Monday morning. Free. Unsubscribe anytime.

life sciencespharmagovernment staffingregulatory affairs

Related stories